SCHEMBL4960062

SCHEMBL4960062

CC(O)c1ccc2[nH]c3ncccc3c2c1.CC(c1ccc2[nH]c3ncccc3c2c1)S(=O)(=O)c1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MET P08581 1/20 0.39
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
CHEK1 O14757 1/20 0.36
KAT2B Q92831 3/20 0.36
BRD4 O60885 1/20 0.36
ALK Q9UM73 1/20 0.36
AURKA O14965 1/20 0.36
PARP1 P09874 1/20 0.36
SLC40A1 Q9NP59 3/20 0.35
MAPT P10636 2/20 0.35
TP53 P04637 1/20 0.35
CYP3A4 P08684 1/20 0.35
TSHR P16473 1/20 0.35
NPY1R P25929 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
ADORA2A P29274 1/20 0.34
ADORA1 P30542 1/20 0.34
FFAR2 O15552 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4960647 0.94 MET (0.42) METMEN1KMT2ACHEK1KAT2B
SCHEMBL4960988 0.85 CHEK1 (0.47) MEN1KMT2ACHEK1ALKAURKA
SCHEMBL4962608 0.78 ALK (0.37) ALKAURKA
SCHEMBL4959114 0.77 BRD4 (0.43) MEN1KMT2ACHEK1BRD4ALK
SCHEMBL30304698 0.75 CHEK1 (0.49) MEN1KMT2ACHEK1ALKAURKA
SCHEMBL5447092 0.74 ALK (0.53) ALK
SCHEMBL5455657 0.73 PARP1 (0.35) BRD4PARP1MAPT
SCHEMBL14594978 0.71 BRD4 (0.68) BRD4SLC40A1SMN1; SMN2MMP2
SCHEMBL14594981 0.70 GAA (0.46) METMEN1KMT2ACHEK1AURKA
SCHEMBL4958627 0.69 MEN1 (0.42) METMEN1KMT2ACHEK1BRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1896472-A1 ALPHA-CARBOLINES AS CDK-1 INHIBITORS Boehringer Ingelheim International GmbH (DE) 2008-03-12 EP disclosed
WO-2006131552-A1 ALPHA-CARBOLINES AS CDK-1 INHIBITORS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2006-12-14 WO disclosed